Discover how synthetic, backbone-free DNA offers a safer, scalable alternative to traditional plasmid DNA for AAV production, addressing key challenges in transfection efficiency, cost, and impurity control.
Find out how our cell-free DNA technology could accelerate your genetic medicine projects.
Sign up for our newsletter, Cell-Free Insights
Touchlight pioneers scalable, cell-free DNA technology, transforming gene therapy and genetic medicine. With a commitment to innovation, excellence, and a diverse team, we push boundaries to deliver safer, more efficient solutions for the future.
© 2025 Touchlight Privacy Policy / Cookie Policy / Policies & Statements / Terms of Use / Suppliers / Biosecurity Commitment
